A Phase II, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Centre Study To Assess the Activity Of Once-Daily Orally Administered ZD4054 15MG and 10MG Doses On Bone Metastases In Pain-Free Or Mildly Systematic Patients..

Project Details

Short titleA Phase II, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Centre Study To Assess the Activity Of Once-Daily Orally Administered ZD4054 15MG and 10MG Doses On Bone Metastases In Pain-Free Or Mildly Systematic Patients..
StatusFinished
Effective start/end date1/01/05 → 31/12/07

Funding

  • Queen Elizabeth Hospital Birmingham